Global Infertility Drugs Market Growth (Status and Outlook) 2025-2031

Global Infertility Drugs Market Growth (Status and Outlook) 2025-2031

The global Infertility Drugs market size is predicted to grow from US$ 5608 million in 2025 to US$ 7777 million in 2031; it is expected to grow at a CAGR of 5.6% from 2025 to 2031.

Infertility Drugs are drugs which enhance reproductive fertility. For women, Infertility Drugs is used to stimulate follicle development of the ovary. Agents that enhance ovarian activity can be classified as either Gonadotropin releasing hormone, Estrogen antagonists or Gonadotropins.

Global Infertility Drugs key players include LIVZON, Merck, Abbott, Ferring, etc. Global top four manufacturers hold a share about 45%.

North America is the largest market, with a share about 45%, followed by Europe, and Asia-Pacific, both have a share about 35 percent.

In terms of product, Gonadotropins is the largest segment, with a share nearly 80%. And in terms of application, the largest application is Female, followed by Male.

LPI (LP Information)' newest research report, the “Infertility Drugs Industry Forecast” looks at past sales and reviews total world Infertility Drugs sales in 2024, providing a comprehensive analysis by region and market sector of projected Infertility Drugs sales for 2025 through 2031. With Infertility Drugs sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Infertility Drugs industry.

This Insight Report provides a comprehensive analysis of the global Infertility Drugs landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Infertility Drugs portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Infertility Drugs market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Infertility Drugs and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Infertility Drugs.

This report presents a comprehensive overview, market shares, and growth opportunities of Infertility Drugs market by product type, application, key players and key regions and countries.

Segmentation by Type:
Gonadotropins
Anti-Estrogens
Other

Segmentation by Application:
Male
Female

This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Merck
Ferring
MSD
LIVZON
Abbott
Bayer Zydus Pharma

Please note: The report will take approximately 2 business days to prepare and deliver.